CREB downregulation in vascular disease: a common response to cardiovascular risk
about
Ca2+/calmodulin-dependent protein kinase II function in vascular remodellingMethotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammationCardiac gene expression data and in silico analysis provide novel insights into human and mouse taste receptor gene regulation.Targeting mitochondria to restore failed adaptation to exercise in diabetes.Rho/ROCK signal cascade mediates asymmetric dimethylarginine-induced vascular smooth muscle cells migration and phenotype change.Impaired response to exercise intervention in the vasculature in metabolic syndrome.cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.PKCε-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosisGlomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesityDiet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels.CaMKIIδ-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscleMolecular mechanisms of hypolipidemic effects of curcumin.Vascular smooth muscle cell phenotype is defined by Ca2+-dependent transcription factors.Beyond phosphorylation: nuclear export in vascular remodeling.The cyclic AMP response element-binding protein (CREB) mediates smooth muscle cell proliferation in response to angiotensin II.Oxidative stress in mesenchymal stem cell senescence: regulation by coding and non-coding RNAs.Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells.Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression.CREB Negatively Regulates IGF2R Gene Expression and Downstream Pathways to Inhibit Hypoxia-Induced H9c2 Cardiomyoblast Cell Death.Overexpression of CREB protein protects from tunicamycin-induced apoptosis in various rat cell types.CXCL5 stimulation of RANK ligand expression in Paget's disease of bone.The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.Prostaglandin E1 Attenuates Pulmonary Artery Remodeling by Activating Phosphorylation of CREB and the PTEN Signaling Pathway.Transcription factor cAMP response element modulator (Crem) restrains Pdgf-dependent proliferation of vascular smooth muscle cells in mice.Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells.A systems biology and proteomics-based approach identifies SRC and VEGFA as biomarkers in risk factor mediated coronary heart disease.Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling.Dual Role of CREB in The Regulation of VSMC Proliferation: Mode of Activation Determines Pro- or Anti-Mitogenic Function.Metformin Modulates High Glucose-Incubated Human Umbilical Vein Endothelial Cells Proliferation and Apoptosis Through AMPK/CREB/BDNF Pathway
P2860
Q26830342-82ADC497-6186-4779-A34F-7417561B2173Q27320563-7E97BB24-7489-44C6-995C-2DF1CD15832FQ30953728-9BBDFEDF-9075-4485-A79A-AE1AF26794EAQ33919949-DC2366CC-0A64-4954-AC51-D8AE89D5C010Q33994067-F0316CED-7AD3-4E44-B375-7421502BE79EQ34070662-72024FA8-BA3C-42E6-A1C3-9409D0A38D29Q35033109-E0802413-9E18-4CCD-BE3A-869B10915B50Q35606379-2E7C570D-5A0B-4042-B738-1AC66643BDD9Q36730493-F2A21A73-3F78-466A-BD84-29DAA6CC1CE7Q36824078-4C5C5BAC-1BD0-4CDC-B0DF-755A4ECB67CFQ37333690-7827887A-8BC5-440F-8A7F-929A7959E5E5Q38075862-EAB2EC90-0659-4DFA-9212-C40DE9A0C594Q38121164-F36B382D-2190-44C1-8207-AD759B131602Q38264544-47BCE888-9874-4407-A86C-25B45B412E8EQ38586360-D5D439ED-7022-4E01-B892-000C4F206DB4Q38648719-7C840E44-D055-4955-8D07-3E6217C4086CQ38721729-EA455B75-2C0A-4965-A44F-8E9770AD5381Q38760996-DA1419B9-B379-4788-8766-D5BE5281FD20Q38816393-D62B329F-ED20-4E93-AF98-782D9FD1A0ACQ39005322-866A96F3-BFF9-46B3-A931-3D4101F7A811Q39188901-8E5056DA-0C49-4A38-8F40-DD4C60BE08EDQ40254224-CB47DC65-05B8-472F-A343-72B84297C7BBQ41564326-8F832CD5-645D-40BD-B1AD-681E33AAC0A5Q41884604-B50AE06A-7265-4D1B-9C61-DDAEDB1E151BQ45858131-D3B9E7C9-F679-4C34-A2A9-41FB09AB3DDEQ50630756-5DABC8A1-80BB-4EBE-81AF-5AB172B64A8BQ54115193-0BDA67C5-1219-4CB7-A939-17A47794B627Q55271401-A8EF9914-F132-458B-8340-0778110B08D8Q59128194-57B4123E-6FE3-40D0-94B8-A5AE3160A4A7
P2860
CREB downregulation in vascular disease: a common response to cardiovascular risk
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CREB downregulation in vascular disease: a common response to cardiovascular risk
@ast
CREB downregulation in vascular disease: a common response to cardiovascular risk
@en
type
label
CREB downregulation in vascular disease: a common response to cardiovascular risk
@ast
CREB downregulation in vascular disease: a common response to cardiovascular risk
@en
prefLabel
CREB downregulation in vascular disease: a common response to cardiovascular risk
@ast
CREB downregulation in vascular disease: a common response to cardiovascular risk
@en
P2093
P2860
P1476
CREB downregulation in vascular disease: a common response to cardiovascular risk
@en
P2093
Alan Chait
Catherine Gliwa
Dwight J Klemm
Irene E Schauer
Jody M Gunter
Katherine E Lewis
Kevin D O'Brien
Leslie A Knaub
Monique Lloyd
Peter A Watson
P2860
P304
P356
10.1161/ATVBAHA.109.199133
P407
P50
P577
2010-02-11T00:00:00Z